NO20013978L - Dopamin D1 reseptor agonist forbindelser - Google Patents

Dopamin D1 reseptor agonist forbindelser

Info

Publication number
NO20013978L
NO20013978L NO20013978A NO20013978A NO20013978L NO 20013978 L NO20013978 L NO 20013978L NO 20013978 A NO20013978 A NO 20013978A NO 20013978 A NO20013978 A NO 20013978A NO 20013978 L NO20013978 L NO 20013978L
Authority
NO
Norway
Prior art keywords
dopamine
receptor agonist
agonist compounds
compounds
receptor
Prior art date
Application number
NO20013978A
Other languages
English (en)
Norwegian (no)
Other versions
NO20013978D0 (no
Inventor
Gary Tilbrook
Original Assignee
Cenes Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cenes Ltd filed Critical Cenes Ltd
Publication of NO20013978L publication Critical patent/NO20013978L/no
Publication of NO20013978D0 publication Critical patent/NO20013978D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
NO20013978A 1999-02-17 2001-08-15 Dopamin D1 reseptor agonist forbindelser NO20013978D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9903671.7A GB9903671D0 (en) 1999-02-17 1999-02-17 Dopamine D-1 receptor agonist compounds
PCT/GB2000/000570 WO2000049000A1 (en) 1999-02-17 2000-02-17 Dopamine d1 receptor agonist compounds

Publications (2)

Publication Number Publication Date
NO20013978L true NO20013978L (no) 2001-08-15
NO20013978D0 NO20013978D0 (no) 2001-08-15

Family

ID=10847990

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013978A NO20013978D0 (no) 1999-02-17 2001-08-15 Dopamin D1 reseptor agonist forbindelser

Country Status (17)

Country Link
EP (1) EP1157009A1 (zh)
JP (1) JP2002537288A (zh)
KR (1) KR20010108228A (zh)
CN (1) CN1142916C (zh)
AU (1) AU767332B2 (zh)
BR (1) BR0008329A (zh)
CA (1) CA2363695A1 (zh)
CZ (1) CZ20012973A3 (zh)
EA (1) EA004745B1 (zh)
GB (1) GB9903671D0 (zh)
HU (1) HUP0200057A3 (zh)
IL (1) IL144810A0 (zh)
MX (1) MXPA01008294A (zh)
NO (1) NO20013978D0 (zh)
PL (1) PL349838A1 (zh)
WO (1) WO2000049000A1 (zh)
ZA (1) ZA200106478B (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0130576D0 (en) * 2001-12-20 2002-02-06 Cenes Ltd Dopamine D1 receptor agonist pro-drug compounds & derivatives
KR101594898B1 (ko) 2005-07-15 2016-02-18 알바니 몰레큘라 리써치, 인크. 아릴- 및 헤테로아릴-치환된 테트라히드로벤자제핀, 및 노르에피네프린, 도파민 및 세로토닌의 재흡수를 차단하기 위한 용도
AU2006278514A1 (en) * 2005-08-03 2007-02-15 Mia Levite Killing human lymphoma and leukemia cancer cells and TCR-activated normal human cells by dopamine D1R agonists
CN101684096A (zh) * 2008-09-23 2010-03-31 中国科学院上海药物研究所 一类新型苯并氮杂卓类化合物及其制备方法和用途
CN102276531A (zh) * 2011-05-30 2011-12-14 扬子江药业集团广州海瑞药业有限公司 一种甲磺酸非诺多泮的制备方法
RS59018B1 (sr) 2013-06-27 2019-08-30 Pfizer Heteroaromatična jedinjenja i njihova upotreba kao dopamin d1 liganada

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1561305A (en) * 1975-07-02 1980-02-20 Smithkline Corp Benzazepine derivatives and pharmeceutical compositions containing them
US4111957A (en) * 1977-02-02 1978-09-05 Smithkline Corporation Substituted 1-thienyl and furyl-2,3,4,5-tetrahydro-1H-3-benzazepine compounds
US4265889A (en) * 1978-05-05 1981-05-05 Smithkline Corporation 6-Lower alkyl-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
US4707483A (en) * 1985-12-20 1987-11-17 Smithkline Beckman Corporation 1-phenyl-3-benzazepines and their use for treating gastrointestinal motility disorders
US4861771A (en) * 1989-01-27 1989-08-29 Smithkline Beckman Corporation Carbamates of 6-chloro-7,8-dihydroxy-1-(4'-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine as prodrugs

Also Published As

Publication number Publication date
KR20010108228A (ko) 2001-12-07
EA004745B1 (ru) 2004-08-26
AU767332B2 (en) 2003-11-06
ZA200106478B (en) 2002-02-07
IL144810A0 (en) 2002-06-30
GB9903671D0 (en) 1999-04-14
HUP0200057A2 (en) 2002-08-28
EP1157009A1 (en) 2001-11-28
AU2563200A (en) 2000-09-04
MXPA01008294A (es) 2002-07-02
WO2000049000A1 (en) 2000-08-24
CN1142916C (zh) 2004-03-24
PL349838A1 (en) 2002-09-23
BR0008329A (pt) 2002-01-29
CA2363695A1 (en) 2000-08-24
EA200100783A1 (ru) 2002-02-28
CZ20012973A3 (cs) 2002-01-16
CN1341102A (zh) 2002-03-20
NO20013978D0 (no) 2001-08-15
JP2002537288A (ja) 2002-11-05
HUP0200057A3 (en) 2004-03-29

Similar Documents

Publication Publication Date Title
DK1189916T3 (da) N-pyrazol A 2A-receptoragonister
DK1446379T3 (da) Arylanilin-beta2-adrenergiske receptoragonister
ATE449768T1 (de) Triazolverbindungen mit dopamin-d3- rezeptoraffinität
DE69903953T2 (de) 2-substituierte-1-piperidyl-benzimidazolverbindungen als orl1 rezeptor agonisten
DE60132799D1 (de) Peroxisom proliferator aktivierten rezeptor alpha agonisten
PT1347760E (pt) Composicoes farmaceuticas de agonista do receptor de nmda
DE60018989D1 (de) N-carbamoyloxyalkyl-substituierte azolium-verbindungen
NO20042737L (no) Peroksisomproliferatoraktiverte receptoragonister
NO20013997D0 (no) Reseptoranalyse
NO20016077D0 (no) Makrofag-oppfanger-reseptorantagonister
NO20016053L (no) IL-8 reseptor-antagonister
MA26890A1 (fr) Metabolites agonistes/ antagonistes d'oestrogenes
DE60130000D1 (de) Zwitterionische tachykinin-rezeptor-antagonisten
NO20016052L (no) IL-8-reseptor-antagonister
DK1146874T3 (da) Vitronectinreceptoragonist
NO20013978L (no) Dopamin D1 reseptor agonist forbindelser
DE60033145D1 (de) Il-8 rezeptorantagonist
ATE264301T1 (de) Muscarin-antagonisten
NO20015774L (no) IL-8 reseptorantagonister
NO20021295L (no) Nikotinsyreacetylcholin-reseptor
GB0130576D0 (en) Dopamine D1 receptor agonist pro-drug compounds & derivatives
NO20016065D0 (no) IL-8-reseptor-antagonister
DK1207159T3 (da) Heteroaromatiske derivater som dopamin-D4-receptorantagonister
DK1450770T3 (da) Farmaceutisk præparat, der omfatter en 5HT1-receptoragonist
SE0003996D0 (sv) Receptorantagonister

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application